Artificial Intelligence in Medicine
Volume 47, Issue 1 , Pages 63-74 , September 2009

A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy

  • Dechao Wang

      Affiliations

    • The HIV Resistance Response Database Initiative (RDI), 14 Union Square, London, UK
    • ,
  • Brendan Larder

      Affiliations

    • The HIV Resistance Response Database Initiative (RDI), 14 Union Square, London, UK
    • ,
  • Andrew Revell

      Affiliations

    • The HIV Resistance Response Database Initiative (RDI), 14 Union Square, London, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 020 7226 7314; fax: +44 020 7226 7314.
    • ,
  • Julio Montaner

      Affiliations

    • BC Centre for Excellence in HIV/AIDS, Vancouver, Canada
    • ,
  • Richard Harrigan

      Affiliations

    • BC Centre for Excellence in HIV/AIDS, Vancouver, Canada
    • ,
  • Frank De Wolf

      Affiliations

    • Netherlands HIV Monitoring Foundation, Amsterdam, The Netherlands
    • ,
  • Joep Lange

      Affiliations

    • Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • Scott Wegner

      Affiliations

    • Uniformed Services University of the Health Sciences, Bethesda, MD, USA
    • ,
  • Lidia Ruiz

      Affiliations

    • Fundació irsiCaixa, Badalona, Spain
    • ,
  • María Jésus Pérez-Elías

      Affiliations

    • Ramón y Cajal Hospital, Madrid, Spain
    • ,
  • Sean Emery

      Affiliations

    • National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia
    • ,
  • Jose Gatell

      Affiliations

    • Hospital Clinic of Barcelona, Barcelona, Spain
    • ,
  • Antonella D’Arminio Monforte

      Affiliations

    • University of Milan (on behalf of ICONA), Milan, Italy
    • ,
  • Carlo Torti

      Affiliations

    • Institute for Infectious and Tropical Diseases, University of Brescia (on behalf of the Italian MASTER Cohort), Brescia, Italy
    • ,
  • Maurizio Zazzi

      Affiliations

    • University of Siena (on behalf of the Italian ARCA database), Siena, Italy
    • ,
  • Clifford Lane

      Affiliations

    • National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA

Received 21 August 2008 ,Revised 16 April 2009 ,Accepted 10 May 2009.

References 

  1. Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis. 2008;47(2):266–285
  2. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington, DC: Department of Health and Human Services; May 4, 2006.
  3. Vandamme AM, Sönnerborg A, Ait-Khaled M, Albert J, Asjo B, Bacheler L, et al. Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther. 2004;6:829–848
  4. Ormaasen V, Sandvik L, Asjo B, Holberg-Petersen M, Gaarder P, Bruun J. An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy. HIV Med. 2004;5:400–406
  5. Wang K, Jenwitheesuk E, Samudrala R, Mittler JE. Simple linear model provides highly accurate genotypic predictions of HIV-1 drug resistance. Antivir Ther. 2004;9:343–352
  6. Sturmer M, Doerr HW, Preiser W. Variety of interpretation systems for human immunodeficiency virus type 1 genotyping: confirmatory information or additional confusion?. Curr Drug Targets Infect Disord. 2003;3:373–382
  7. Shapiro JM, De Luca A, Harrigan PR, Hellmann N, McCreedy B, Pillay D, et al. Resistance assay interpretation systems vary widely in method and approach. Antivir Ther. 2001;6(Suppl. 1):131
  8. Gallego O, Martin-Carbonero L, Aguero J, de Mendoza C, Corral A, Soriano V. Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals. J Virol Methods. 2004;121:115–118
  9. Beerenwinkel N, Däumer M, Oette M, Korn K, Hoffmann D, Kaiser R, et al. Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes. Nucleic Acids Res. 2003;31:3850–3855
  10. Shafer RW, Gonzales MJ, Brun-Vezinet F. Online comparison of HIV-1 drug resistance algorithms identifies rates and causes of discordant interpretations. Antivir Ther. 2001;6:101
  11. Torti C, Quiros-Roldan E, Keulen W, Scudeller L, Lo Caputo S, Boucher C, et al. Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patients. J Infect Dis. 2003;188:194–201
  12. Sturmer M, Doerr HW, Staszewski S, Preiser W. Comparison of nine resistance interpretation systems for HIV-1 genotyping. Antivir Ther. 2003;8:239–244
  13. De Luca A, Cingolani A, Di Giambenedetto S, Trotta M, Baldini F, Rizzo MG, et al. Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance. J Infect Dis. 2003;15:1934–1943
  14. Beerenwinkel N, Sing T, Lengauer T, Rahnenführer J, Roomp K, Savenkov I, et al. Computational models for the design of effective therapies against drug resistant HIV strains. Bioinformatics. 2005;21(21):3943–3950
  15. Wang D, Larder B. Enhanced prediction of lopinavir resistance from genotype by use of artificial neural networks. J Infect Dis. 2003;188:653–660
  16. Beerenwinkel N, Schmidt B, Walter H, Kaiser R, Lengauer T, Hoffmann D, et al. Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype. Proc Natl Acad Sci USA. 2002;99(12):8271–8276
  17. Larder BA, Kemp SD, Hertogs K. Quantitative prediction of HIV-1 phenotypic drug resistance from genotypes: the virtual phenotype (VirtualPhenotype). Antivir Ther. 2000;5(Suppl. 3):49
  18. Brun-Vezinet F, Costagliola D, Ait Khaled M, Calvez V, Clavel F, Clotet B, et al. Clinically validated genotype analysis: guiding principles and statistical concerns. Antivir Ther. 2004;9(4):465–478
  19. Bachelor LT, Winters B, Nauwelaers D, Rinehart A, McGregor M, Harrigan R, et al. Estimation of phenotypic clinical cut-offs for VirtualPhenotype through meta analyses of clinical trial and cohort data. Antivir Ther. 2004;9:S154
  20. Swanstrom R, Bosch RJ, Katzenstein D, Cheng H, Jiang H, Hellmann N, et al. Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects. J Infect Dis. 2004;190:886–893
  21. DiRienzo G, DeGruttola V. Collaborative HIV resistance-response database: sample size for detection of relationships between HIV-1 genotype and HIV-1 RNA response using a non-parametric approach. Antivir Ther. 2002;7:S71
  22. Larder BA, DeGruttola V, Hammer S, Harrigan R, Wegner S, Winslow D, et al. The international HIV resistance response database initiative: a new global collaborative approach to relating viral genotype treatment to clinical outcome. Antivir Ther. 2002;7:S84
  23. Larder B, Wang D, Revell A, Montaner J, Harrigan R, DeWolf F, et al. The development of artificial neural networks to predict virological response to combination HIV therapy. Antivir Ther. 2007;12:15–24
  24. Liaw A, Wiener M. Classification and regression by random forest. R News. 2002;2–3:18–22
  25. Breiman L. Random forests. Mach Learn. 2001;45:5–32
  26. Onkamo P, Toivonen H. A survey of data mining methods for linkage disequilibrium mapping. Hum Genom. 2006;2:336–340
  27. Listgarten J, Damaraju S, Poulin B, Cook L, Dufour J, Driga A, et al. Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. Clin Cancer Res. 2004;10:2725–2737
  28. Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, Haussler D. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics. 2000;16(10):906–914
  29. Bartlett P, Shawe-Taylor J. Generalization performance of support vector machines and other pattern classifiers. In:  Schoelkopf B,  Burges CJC,  Smola AJ editor. Advances in Kernel methods—support vector learning. Boston: MIT Press; 1999;p. 43–54
  30. Larder BA, Wang D, Revell A, Lane C. Neural network model identified potentially effective drug combinations for patients failing salvage therapy. In: The 2nd IAS conference on HIV pathogenesis and treatment, Paris, France, 13–16 July. 2003;[Poster LB39]
  31. Breiman and Cutler's random forests for classification and regression. http://cran.r-project.org/web/packages/randomForest/index.html [accessed 30 November 2007].
  32. Shrestha DL, Solomatine DP. Machine learning approaches for estimation of prediction interval for the model output. Neural Networks. 2006;19:225–235
  33. Heske T. Bias/variance decompositions for likelihood-based estimators. Neural Comput. 1998;10:1425–1433

PII: S0933-3657(09)00082-7

doi: 10.1016/j.artmed.2009.05.002

Artificial Intelligence in Medicine
Volume 47, Issue 1 , Pages 63-74 , September 2009

Article Tools

* Image Usage & Resolution